
Sign up to save your podcasts
Or
In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.
4.7
1818 ratings
In the United States, about 80 percent of tests used to diagnose C. difficile are PCR assays. So what are the best options to diagnose and treat patients with this infection? To discuss the evolving treatment and evaluation landscape for C. difficile, Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor at Yale New Haven Hospital.
7 Listeners
69 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
14 Listeners
0 Listeners
2,430 Listeners
3,332 Listeners
111,785 Listeners
1,090 Listeners
3,363 Listeners
7,928 Listeners
185 Listeners
248 Listeners
249 Listeners
366 Listeners
33 Listeners
16 Listeners
11 Listeners